A randomized controlled trial demonstrating sustained benefit of Autologous Matrix-Induced Chondrogenesis over microfracture at five years

Purpose Autologous Matrix-Induced Chondrogenesis (AMIC ® ) utilizing a type I/III collagen membrane was compared with microfracture (MFx) alone in focal cartilage lesions of the knee at one, two and five years. Methods Forty-seven patients (aged 37 ± 10 years, mean defect size 3.6 ± 1.6 cm 2 ) were randomized and treated either with MFx, with sutured or glued AMIC ® in a prospective multicentre clinical trial. Results After improvement for the first two years in all subgroups, a progressive and significant score degradation was observed in the MFx group, while all functional parameters remained stable for least five years in the AMIC ® groups. At two and five years, MRI defect filling was more complete in the AMIC ® groups. No treatment-related adverse events were reported. Conclusions AMIC ® is an effective cartilage repair procedure in the knee resulting in stable clinical results significantly better than the MFx group at five years.